Lytix Biopharma
Research - Oslo, Oslo, Norway
Lytix Biopharma Senior Management
Lytix Biopharma Details
Lytix Biopharma is a private clinical-stage biotech company developing proprietary oncolytic peptides as a novel immune therapy to fight cancer. Lead compound LTX-315 provides access to antigens by using the patient's own tumor as source of antigens and turns cold tumors hot. Local treatment with LTX-315 targets the first step in the cancer immunity cycle with a potential cornerstone position in immunotherapy.
Website:
http://www.lytixbiopharma.com
Employees:
19
HQ:
+1 477-767-5500
Location:
Oslo, Oslo, Norway
Revenue:
2.4M
Lytix Biopharma Technologies
Email Providers
Outlook
Fonts
Google Font API
Other
Microsoft Office 365
Analytics and Tracking
Google Analytics
Online Video Platforms
Vimeo
CSS and JavaScript Libraries
Bootstrap Framework